Pyxis Oncology is trading 6.98% up now at $3.30 in after-hours trading, with the move appearing more consistent with favorable broader-market sentiment than a confirmed company-specific catalyst.
- It closed at $3.08 on August 21, 2026.
- The company filed a prospectus covering resale of up to 39,200,306 shares by selling stockholders; it does not represent a new company share issuance or provide operating news.
- The Nasdaq and S&P 500 advanced during the regular session; after-hours volume and activity levels were unavailable.